Tissue Regenix Group plc

AIM:TRX Stock Report

Market Cap: UK£42.4m

Tissue Regenix Group Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

AIM:TRX Recent Insider Transactions by Companies or Individuals
DateValueNameEntityRoleSharesMax Price
13 Dec 24BuyUK£1,097Lombard Odier Asset Management (Europe) Ltd.Company1,892UK£0.58
11 Dec 24BuyUK£1,134Cenkos Securities plc, Asset Management ArmCompany1,982UK£0.57
11 Dec 24SellUK£16,165Cenkos Securities plc, Asset Management ArmCompany27,500UK£0.59
09 Dec 24BuyUK£50,850Lombard Odier Asset Management (Europe) Ltd.Company90,000UK£0.57
06 Dec 24BuyUK£14,250Lombard Odier Asset Management (Europe) Ltd.Company25,000UK£0.57
05 Dec 24SellUK£1,200,025IP Group PlcCompany2,069,008UK£0.58
04 Dec 24BuyUK£6,941Lombard Odier Asset Management (Europe) Ltd.Company12,178UK£0.57
11 Nov 24SellUK£4,994Cenkos Securities plc, Asset Management ArmCompany7,889UK£0.63

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Ownership Breakdown

What is the ownership structure of TRX?
Owner TypeNumber of SharesOwnership Percentage
Public Companies123,1690.173%
Employee Share Scheme161,0680.226%
Private Companies6,529,0849.17%
VC/PE Firms9,030,03412.7%
Individual Insiders12,447,19717.5%
General Public12,673,86417.8%
Institutions30,270,09142.5%

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.

Top Shareholders

Top 25 shareholders own 78.85% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
15.2%
Richard Sneller
10,859,000UK£6.5m4.32%no data
15.1%
Harwood Capital LLP
10,740,000UK£6.4m1.51%0.64%
12.8%
Lombard Odier Asset Management (Europe) Ltd.
9,109,021UK£5.4m7.27%0.11%
6.41%
Ora Ventures Limited
4,568,614UK£2.7m0%100.0%
6.26%
IP Group Plc
4,461,420UK£2.7m-31.7%1.88%
4.71%
Ora Global Limited
3,355,076UK£2.0m4.93%no data
2.9%
Lexham Special Opportunities I LP
2,069,008UK£1.2m0%no data
2.68%
Barclays Bank PLC, Wealth and Investment Management Division
1,908,162UK£1.1m-10.4%0.01%
2.66%
HBOS Investment Fund Managers Limited
1,893,477UK£1.1m-12.5%0.01%
1.55%
Stockinvest Limited
1,105,000UK£657.5k0%no data
1.21%
IG Group Holdings Plc, Asset Management Arm
862,611UK£513.3k-20.2%0.05%
0.8%
Jarvis Securities plc, Asset Management Arm
566,414UK£337.0k-0.01%0.03%
0.71%
Close Asset Management Limited
508,174UK£302.4k24%no data
0.65%
Canaccord Genuity Wealth (International) Ltd.
462,750UK£275.3k-13.1%0.01%
0.57%
HSBC Global Asset Management (UK) Limited
409,057UK£243.4k-11.6%no data
0.57%
Jonathan Glenn
406,000UK£241.6k0%no data
0.55%
Heather Sneller
395,000UK£235.0k-16%no data
0.55%
JM Finn & Co Ltd.
390,977UK£232.6k20.8%0.01%
0.53%
Maunby Investment Management Ltd.
374,250UK£222.7k0%13.07%
0.48%
The University of Leeds, Endowment Arm
339,800UK£202.2k0%25.16%
0.47%
Stifel Asset Management Corp.
335,736UK£199.8k208%no data
0.42%
KBC Group NV, Banking and Securities Investments
300,109UK£178.6k-6.19%0.17%
0.4%
Daniel Lee
282,512UK£168.1k0%no data
0.33%
Lombard Odier Asset Management (USA) Corp
236,219UK£140.6k0%0.05%
0.32%
Charles Stanley & Co. Ltd, Asset Management Arm
227,378UK£135.3k-9.99%no data

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/19 18:46
End of Day Share Price 2024/12/19 00:00
Earnings2024/06/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Tissue Regenix Group plc is covered by 8 analysts. 2 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Mark BrewerCavendish
Christopher DonnellanCavendish
Vadim Alexandre KhalilDaniel Stewart & Company